brand and compounded Semaglutide, tirzepatide primarily Compounded semaglutide, tirzepatide, microdose GLP-1, GLP-Squared dual Genetic or Biomarker Testing No standard genetic pathway assessment No standard genetic pathway assessment Optional Precision Peptide Genetic Test for pathway predispositions Behavioral Support Included Limited
Hirabayashi, Y
Protects Against Environmental Damage: Daily exposure to UV rays, pollution, and blue light can weaken skin cells
For patients transitioning from semaglutide, recent labs are reviewed and updated as needed
The right pathway depends on your health history, BMI, metabolic conditions, lifestyle and long-term goals
Novo Nordisk is committed to the responsible use of our semaglutide-containing medicines which represent distinct products with different indications, dosages, prescribing information, titration schedules, and delivery forms